Cargando…
Untargeted Metabolomics for Autism Spectrum Disorders: Current Status and Future Directions
Autism spectrum disorders (ASDs) are a group of neurodevelopment disorders characterized by childhood onset deficits in social communication and interaction. Although the exact etiology of most cases of ASDs is unknown, a portion has been proposed to be associated with various metabolic abnormalitie...
Autores principales: | Glinton, Kevin E., Elsea, Sarah H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6746843/ https://www.ncbi.nlm.nih.gov/pubmed/31551836 http://dx.doi.org/10.3389/fpsyt.2019.00647 |
Ejemplares similares
-
Zebrafish Modeling of Autism Spectrum Disorders, Current Status and Future Prospective
por: Tayanloo-Beik, Akram, et al.
Publicado: (2022) -
Untargeted metabolomics identifies unique though benign biochemical changes in patients with pathogenic variants in UROC1
por: Glinton, Kevin E., et al.
Publicado: (2018) -
Imaging-Genetics in Autism Spectrum Disorder: Advances, Translational Impact, and Future Directions
por: Ameis, Stephanie H., et al.
Publicado: (2012) -
Untargeted Metabolomics of Slc13a5 Deficiency Reveal Critical Liver–Brain Axis for Lipid Homeostasis
por: Milosavljevic, Sofia, et al.
Publicado: (2022) -
Comparison of Untargeted Metabolomic Profiling vs Traditional Metabolic Screening to Identify Inborn Errors of Metabolism
por: Liu, Ning, et al.
Publicado: (2021)